Arvinas (ARVN) Short Interest Ratio & Short Volume $17.77 -0.60 (-3.27%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$17.95 +0.18 (+1.01%) As of 02/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Arvinas Short Interest DataArvinas (ARVN) has a short interest of 10.44 million shares. This marks a 6.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.8, indicating that it would take 11.8 days of the average trading volume of 974,833 shares to cover all short positions.Current Short Interest10,440,000 sharesPrevious Short Interest9,760,000 sharesChange Vs. Previous Month+6.97%Dollar Volume Sold Short$183.85 millionShort Interest Ratio11.8 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares68,770,000 sharesPercentage of Shares Shorted15.18%Today's Trading Volume1,871,324 sharesAverage Trading Volume974,833 sharesToday's Volume Vs. Average192% Short Selling Arvinas? Sign up to receive the latest short interest report for Arvinas and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARVN Short Interest Over TimeARVN Days to Cover Over TimeARVN Percentage of Float Shorted Over Time Arvinas Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/202510,440,000 shares $183.85 million +7.0%N/A11.8 $17.61 1/15/20259,760,000 shares $173.04 million +3.0%N/A11.9 $17.73 12/31/20249,480,000 shares $181.73 million -1.4%N/A12.3 $19.17 12/15/20249,610,000 shares $187.40 million +6.5%N/A13.4 $19.50 11/30/20249,020,000 shares $241.01 million +5.6%N/A15.6 $26.72 11/15/20248,540,000 shares $191.98 million -3.0%N/A15.2 $22.48 10/31/20248,800,000 shares $232.58 million -5.6%N/A16.1 $26.43 10/15/20249,320,000 shares $241.39 million -12.7%N/A16 $25.90 9/30/202410,670,000 shares $262.80 million -16.4%N/A16.5 $24.63 9/15/202412,760,000 shares $319.64 million -3.2%N/A17.4 $25.05 Get the Latest News and Ratings for ARVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arvinas and its competitors with MarketBeat's FREE daily newsletter. 8/31/202413,180,000 shares $344.79 million +10.3%N/A17 $26.16 8/15/202411,950,000 shares $305.92 million +11.4%N/A13.9 $25.60 7/31/202410,730,000 shares $295.18 million +0.9%N/A12.3 $27.51 7/15/202410,640,000 shares $318.88 million +11.5%N/A12.5 $29.97 6/30/20249,540,000 shares $253.95 million +5.8%N/A11.9 $26.62 6/15/20249,020,000 shares $231.54 million +9.3%N/A12.4 $25.67 5/31/20248,250,000 shares $273.41 million -7.6%N/A11.2 $33.14 5/15/20248,930,000 shares $288.71 million +3.1%N/A12.2 $32.33 4/30/20248,660,000 shares $275.13 million -3.1%N/A11.5 $31.77 4/15/20248,940,000 shares $310.40 million +4.0%N/A11.9 $34.72 3/31/20248,600,000 shares $355.01 million +8.6%N/A11.7 $41.28 3/15/20247,920,000 shares $355.21 million -5.2%N/A10.6 $44.85 2/29/20248,350,000 shares $383.93 million +7.5%N/A9.8 $45.98 2/15/20247,770,000 shares $403.50 million +19.5%17.1%8.9 $51.93 1/31/20246,500,000 shares $269.75 million +17.5%13.6%7.7 $41.50 1/15/20245,530,000 shares $214.12 million +16.4%11.5%6.8 $38.72 12/31/20234,750,000 shares $195.51 million +9.5%9.7%6.1 $41.16 12/15/20234,340,000 shares $159.02 million +94.6%8.9%5.7 $36.64 11/30/20232,230,000 shares $48.99 million +4.2%4.7%3.4 $21.97 11/15/20232,140,000 shares $43.44 million -18.0%4.5%4.4 $20.30 10/31/20232,610,000 shares $42.07 million +4.0%5.7%5.8 $16.12 10/15/20232,510,000 shares $42.27 million -18.5%5.5%6.3 $16.84 9/30/20233,080,000 shares $60.49 million +7.7%6.7%8.1 $19.64 9/15/20232,860,000 shares $69.78 million -1.0%6.2%7.7 $24.40 8/31/20232,890,000 shares $81.53 million +4.3%6.3%6.8 $28.21 8/15/20232,770,000 shares $68.20 million -7.1%6.0%6.7 $24.62 7/31/20232,980,000 shares $73.67 million +4.2%6.5%7.1 $24.72 7/15/20232,860,000 shares $69.10 million +1.1%6.2%6.6 $24.16 6/30/20232,830,000 shares $70.24 million +6.4%6.2%6.1 $24.82 6/15/20232,660,000 shares $80.68 million -20.6%5.8%5.6 $30.33[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED (Ad)Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy. Democrats smeared RFK Jr as a fraud, liar and even a murderer…. to stop him from revealing Big Pharma’s biggest secrets… Which is exactly why I’ve made the short video that reveals everything. 5/31/20233,350,000 shares $73.13 million -8.7%7.3%7.7 $21.83 5/15/20233,670,000 shares $87.35 million -10.9%8.0%8.2 $23.80 4/30/20234,120,000 shares $107.99 million -11.8%9.0%9.2 $26.21 4/15/20234,670,000 shares $125.44 million -6.6%10.2%10.8 $26.86 3/31/20235,000,000 shares $136.60 million -2.0%11.0%9.9 $27.32 3/15/20235,100,000 shares $150.65 million +0.6%11.2%10.2 $29.54 2/28/20235,070,000 shares $155.40 million +6.5%11.1%10.3 $30.65 2/15/20234,760,000 shares $161.84 million +7.7%10.4%9 $34.00 1/31/20234,420,000 shares $144.84 million -5.2%9.6%7.9 $32.77 1/15/20234,660,000 shares $156.11 million -10.4%10.2%8.4 $33.50 12/30/20225,200,000 shares $177.89 million -1.1%11.3%10.2 $34.21 12/15/20225,260,000 shares $195.41 million +2.5%11.5%11.4 $37.15 11/30/20225,130,000 shares $210.54 million -4.8%11.2%11.5 $41.04 11/15/20225,390,000 shares $308.52 million -4.3%11.8%12.5 $57.24 10/31/20225,630,000 shares $279.87 million -0.2%12.3%14.5 $49.71 10/15/20225,640,000 shares $239.59 million +4.8%12.3%14.8 $42.48 9/30/20225,380,000 shares $239.36 million -0.9%11.7%14.1 $44.49 9/15/20225,430,000 shares $265.36 million -1.1%11.8%13.5 $48.87 8/31/20225,490,000 shares $232.45 million +8.5%12.0%13.5 $42.34 8/15/20225,060,000 shares $273.85 million +1.0%11.0%12.1 $54.12 7/31/20225,010,000 shares $266.08 million -2.0%11.0%11 $53.11 7/15/20225,110,000 shares $254.73 million -1.9%11.5%10.7 $49.85 6/30/20225,210,000 shares $219.29 million +6.1%11.7%10.6 $42.09 6/15/20224,910,000 shares $187.95 million +6.7%11.0%10.3 $38.28 5/31/20224,600,000 shares $191.77 million +6.0%10.4%9.5 $41.69 5/15/20224,340,000 shares $187.18 million +9.1%9.8%8.7 $43.13 4/30/20223,980,000 shares $218.78 million +14.7%9.0%8.1 $54.97 4/15/20223,470,000 shares $232.35 million -6.7%7.8%7.5 $66.96 3/31/20223,720,000 shares $250.36 million +1.1%8.4%8.3 $67.30 3/15/20223,680,000 shares $221.79 million +18.7%8.3%8.2 $60.27 2/28/20223,100,000 shares $200.91 million No Change7.0%6.4 $64.81 2/15/20223,100,000 shares $226.11 million +11.9%7.0%6.3 $72.94 1/31/20222,770,000 shares $198.03 million +16.9%6.2%6 $71.49 1/15/20222,370,000 shares $159.79 million +1.7%5.4%5.5 $67.42 12/31/20212,330,000 shares $191.39 million -4.1%5.3%5.7 $82.14 12/15/20212,430,000 shares $168.16 million +38.9%5.5%6 $69.20 11/30/20211,750,000 shares $132.32 million +12.9%4.0%4.9 $75.61 11/15/20211,550,000 shares $128.60 million -33.2%3.6%4.7 $82.97 10/29/20212,320,000 shares $200.87 million -2.1%5.6%7.3 $86.58 10/15/20212,370,000 shares $201.69 million +0.9%5.7%6.6 $85.10 9/30/20212,350,000 shares $193.12 million -5.2%5.8%5.4 $82.18 9/15/20212,480,000 shares $235.33 million +2.9%6.4%5.5 $94.89 8/31/20212,410,000 shares $207.77 million -7.3%6.1%4.8 $86.21 8/13/20212,600,000 shares $237.15 million -11.0%6.6%5 $91.21 7/30/20212,920,000 shares $295.21 million -2.0%7.4%5.6 $101.10 7/15/20212,980,000 shares $218.14 million -2.6%7.9%6.3 $73.20 6/30/20213,060,000 shares $235.62 million +5.5%8.2%7.2 $77.00 6/15/20212,900,000 shares $234.84 million +33.6%7.7%6.8 $80.98 5/28/20212,170,000 shares $157.85 million -0.5%5.8%5.5 $72.74 5/14/20212,180,000 shares $139.17 million -10.3%N/A5.6 $63.84[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED (Ad)Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy. Democrats smeared RFK Jr as a fraud, liar and even a murderer…. to stop him from revealing Big Pharma’s biggest secrets… Which is exactly why I’ve made the short video that reveals everything. 4/30/20212,430,000 shares $169.66 million +5.7%N/A6 $69.82 4/15/20212,300,000 shares $144.65 million +2.7%N/A5.2 $62.89 3/31/20212,240,000 shares $140.11 million +17.9%N/A4.6 $62.55 3/15/20211,900,000 shares $146.03 million +6.7%N/A3.2 $76.86 2/26/20211,780,000 shares $131.61 million +8.5%N/A1.6 $73.94 2/12/20211,640,000 shares $129.72 million -1.2%N/A1.4 $79.10 1/29/20211,660,000 shares $122.69 million -7.8%N/A1.4 $73.91 1/15/20211,800,000 shares $157.88 million -70.4%N/A1.5 $87.71 12/31/20206,070,000 shares $500.96 million -8.6%N/A5.3 $82.53 12/15/20206,640,000 shares $387.64 million +3.1%N/A6.1 $58.38 11/30/20206,440,000 shares $159.97 million -2.6%23.1%12.6 $24.84 11/15/20206,610,000 shares $168.22 million +7.8%23.7%13.7 $25.45 10/30/20206,130,000 shares $134.37 million +10.3%22.3%15.1 $21.92 10/15/20205,560,000 shares $140.17 million -1.9%20.9%14.4 $25.21 9/30/20205,670,000 shares $133.87 million +4.0%21.6%15.7 $23.61 9/15/20205,450,000 shares $144.64 million +62.2%20.8%13.6 $26.54 8/31/20203,360,000 shares $87.19 million -10.6%12.9%8.1 $25.95 8/14/20203,760,000 shares $100.35 million -6.9%14.4%7 $26.69 7/31/20204,040,000 shares $127.26 million -1.2%15.5%6.6 $31.50 7/15/20204,090,000 shares $135.87 million -2.4%15.7%6.4 $33.22 6/30/20204,190,000 shares $140.53 million +27.0%16.4%6.5 $33.54 6/15/20203,300,000 shares $101.97 million +13.8%12.9%5.4 $30.90 5/29/20202,900,000 shares $96.48 million +23.9%11.4%5 $33.27 5/15/20202,340,000 shares $105.96 million -9.0%9.2%5.1 $45.28 4/30/20202,570,000 shares $134.93 million -11.4%10.1%6.4 $52.50 4/15/20202,900,000 shares $133.95 million +8.2%12.3%8.4 $46.19 3/31/20202,680,000 shares $140.38 million +16.9%11.4%7.9 $52.38 3/13/20202,292,500 shares $104.97 million +3.3%18.3%7.4 $45.79 2/28/20202,220,000 shares $77.99 million +22.0%17.7%6.8 $35.13 ARVN Short Interest - Frequently Asked Questions What is Arvinas' current short interest? Short interest is the volume of Arvinas shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 10,440,000 shares of ARVN short. Learn More on Arvinas' current short interest. What is a good short interest ratio for Arvinas? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARVN shares currently have a short interest ratio of 12.0. Learn More on Arvinas's short interest ratio. Which institutional investors are shorting Arvinas? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Arvinas: LMR Partners LLP, Group One Trading LLC, Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Diadema Partners LP, Concourse Financial Group Securities Inc., Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Arvinas' short interest increasing or decreasing? Arvinas saw a increase in short interest in January. As of January 31st, there was short interest totaling 10,440,000 shares, an increase of 7.0% from the previous total of 9,760,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Arvinas' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Arvinas: TG Therapeutics, Inc. (19.30%), Krystal Biotech, Inc. (10.47%), SpringWorks Therapeutics, Inc. (19.36%), Biohaven Ltd. (9.34%), Recursion Pharmaceuticals, Inc. (19.74%), PTC Therapeutics, Inc. (5.39%), Organon & Co. (6.46%), Ultragenyx Pharmaceutical Inc. (4.51%), Alvotech (0.37%), Avidity Biosciences, Inc. (12.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Arvinas stock? Short selling ARVN is an investing strategy that aims to generate trading profit from Arvinas as its price is falling. ARVN shares are trading down $0.71 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Arvinas? A short squeeze for Arvinas occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARVN, which in turn drives the price of the stock up even further. How often is Arvinas' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARVN, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies TG Therapeutics Short Squeeze Krystal Biotech Short Squeeze SpringWorks Therapeutics Short Squeeze Biohaven Short Squeeze Recursion Pharmaceuticals Short Squeeze PTC Therapeutics Short Squeeze Organon & Co. Short Squeeze Ultragenyx Pharmaceutical Short Squeeze Alvotech Short Squeeze Avidity Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARVN) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arvinas, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arvinas With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
